Showing results (141-150 of 465) with videos related to
Sort By:
Pageof 47
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 29, 2006
Testicular neoplasms. Evaluation of the experience during 25 years in a military hospitalRamón Diz-Rodríguez, Miguel Vírseda-Chamorro, Pedro Paños-Lozano, et al.Bioengineering (Basel, Switzerland)|March 24, 2022
Validation of Psychophysiological Measures for Caffeine Oral Films Characterization by Machine Learning ApproachesPatrícia Batista, Pedro Miguel Rodrigues, Miguel Ferreira, et al.The Lancet. HIV|June 1, 2020
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohortPilar Vizcarra, María J Pérez-Elías, Carmen Quereda, et al.Journal of the International AIDS Society|November 15, 2014
Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patientsJose Luis Casado, Sara Bañón, Ana Moreno, et al.Journal of the International AIDS Society|November 14, 2014
Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosisJose Luis Casado, Alvaro Mena, Sara Bañón, et al.Stem Cell Reports|September 24, 2021
Programmatic introduction of parenchymal cell types into blood vessel organoidsAmir Dailamy, Udit Parekh, Dhruva Katrekar, et al.AIDS Research and Human Retroviruses|April 29, 2021
Progression Risk in People with HIV and COVID-19: Predictive Performance of Current Risk ScoresPilar Vizcarra, Alfonso Cabello, Ana Moreno, et al.Revista Espanola De Medicina Nuclear E Imagen Molecular|December 19, 2022
[Assessment of pulmonary embolism related to active SARS-CoV-2 infection in pregnant women.]Ana Moreno-Ballesteros, Ángel C Rebollo-Aguirre, Isabel Bolívar-Roldán, et al.Infection|March 31, 2022
Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19José L Casado, Pilar Vizcarra, María J Vivancos, et al.AIDS (London, England)|December 13, 2001
Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimenJose L Casado, Santiago Moreno, Kurt Hertogs, et al.Pageof 47